Determinants of resistance to 2′, 2′-difluorodeoxycytidine (gemcitabine)
AM Bergman, HM Pinedo, GJ Peters - Drug Resistance Updates, 2002 - Elsevier
The inherent or induced resistance of tumors to cytostatic agents is a major clinical problem.
In this review, we summarize the pre-clinical mechanisms of acquired and inherent …
In this review, we summarize the pre-clinical mechanisms of acquired and inherent …
Determinants of resistance to 2', 2'-difluorodeoxycytidine (gemcitabine)
AM Bergman, HM Pinedo… - … updates: reviews and …, 2002 - pubmed.ncbi.nlm.nih.gov
The inherent or induced resistance of tumors to cytostatic agents is a major clinical problem.
In this review, we summarize the pre-clinical mechanisms of acquired and inherent …
In this review, we summarize the pre-clinical mechanisms of acquired and inherent …
Determinants of resistance to 2′, 2′-difluorodeoxycytidine (gemcitabine)
AM Bergman, HM Pinedo… - Drug Resistance …, 2002 - jhu.pure.elsevier.com
The inherent or induced resistance of tumors to cytostatic agents is a major clinical problem.
In this review, we summarize the pre-clinical mechanisms of acquired and inherent …
In this review, we summarize the pre-clinical mechanisms of acquired and inherent …
[引用][C] Determinants of resistance to 2′, 2′-difluorodeoxycytidine (gemcitabine)
AM Bergman, HM Pinedo, GJ Peters - Drug Resistance Updates, 2002 - cir.nii.ac.jp
Determinants of resistance to 2', 2'-difluorodeoxycytidine (gemcitabine)
AM Bergman, HM Pinedo, GJ Peters - Drug Resistance Updates, 2002 - infona.pl
The inherent or induced resistance of tumors to cytostatic agents is a major clinical problem.
In this review, we summarize the pre-clinical mechanisms of acquired and inherent …
In this review, we summarize the pre-clinical mechanisms of acquired and inherent …
Determinants of resistance to 2', 2'-difluorodeoxycytidine (gemcitabine).
AM Bergman, HM Pinedo, GJ Peters - Drug Resistance Updates …, 2002 - europepmc.org
The inherent or induced resistance of tumors to cytostatic agents is a major clinical problem.
In this review, we summarize the pre-clinical mechanisms of acquired and inherent …
In this review, we summarize the pre-clinical mechanisms of acquired and inherent …
Determinants of resistance to 2′, 2′-difluorodeoxycytidine (gemcitabine)
AM Bergman, HM Pinedo… - Drug Resistance …, 2002 - pure.johnshopkins.edu
The inherent or induced resistance of tumors to cytostatic agents is a major clinical problem.
In this review, we summarize the pre-clinical mechanisms of acquired and inherent …
In this review, we summarize the pre-clinical mechanisms of acquired and inherent …
[引用][C] Erratum: Determinants of resistance to 2′, 2′-difluorodeoxycytidine (gemcitabine)(Drug Resistance Updates (2002) 5 (19-33) S136876460200002X)
AM Bergman, HM Pinedo… - Drug Resistance …, 2002 - jhu.pure.elsevier.com
Erratum: Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine) (Drug
Resistance Updates (2002) 5 (19-33) S136876460200002X) — Johns Hopkins University …
Resistance Updates (2002) 5 (19-33) S136876460200002X) — Johns Hopkins University …
[引用][C] Erratum to''Determinants of resistance to 2', 2'-difluorodeoxycytidine (gemcitabine)''-[Drug Resistance Updates 5 (2002) 19-33]
AM Bergman, HM Pinedo, GJ Peters - Drug Resistance Updates, 2002 - infona.pl
Erratum to ''Determinants of resistance to 2',2'-difluorodeoxycytidine (gemcitabine)'' - [Drug
Resistance Updates 5 (2002) 19-33] × Close The Infona portal uses cookies, ie strings of text …
Resistance Updates 5 (2002) 19-33] × Close The Infona portal uses cookies, ie strings of text …